News on Imperial College Innovations Limited from BioPortfolio.com http://www.BioPortfolio.com Consolidated Imperial College Innovations Limited news from BioPortfolio.com Wed, 10 Feb 2010 09:46:37 GMT en Imperial Innovations Group plc Licenses Meningitis B Vaccinehttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3999166&HITNO=0&MSIZE=15&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Imperial%20College%20Innovations%20Limited&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3999166&THISHREF=http://c.moreover.com/click/here.pl%3fz2517343702%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3999166&HITNO=0&MSIZE=15&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Imperial%20College%20Innovations%20Limited&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3999166&THISHREF=http://c.moreover.com/click/here.pl%3fz2517343702%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharma Live: LBT Key European Patent Grantedhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3997932&HITNO=1&MSIZE=15&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Imperial%20College%20Innovations%20Limited&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3997932&THISHREF=http://c.moreover.com/click/here.pl%3fz2516894134%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3997932&HITNO=1&MSIZE=15&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Imperial%20College%20Innovations%20Limited&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3997932&THISHREF=http://c.moreover.com/click/here.pl%3fz2516894134%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharma Live: Imperial Innovations signs licensing agreement with Novartishttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3992881&HITNO=2&MSIZE=15&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Imperial%20College%20Innovations%20Limited&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3992881&THISHREF=http://c.moreover.com/click/here.pl%3fz2514370162%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3992881&HITNO=2&MSIZE=15&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Imperial%20College%20Innovations%20Limited&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3992881&THISHREF=http://c.moreover.com/click/here.pl%3fz2514370162%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comIndividual.com: Imperial Innovations enters pact with Novartishttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3982421&HITNO=3&MSIZE=15&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Imperial%20College%20Innovations%20Limited&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3982421&THISHREF=http://c.moreover.com/click/here.pl%3fz2507449851%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3982421&HITNO=3&MSIZE=15&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Imperial%20College%20Innovations%20Limited&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3982421&THISHREF=http://c.moreover.com/click/here.pl%3fz2507449851%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharmaBiz: Imperial Innovations Group plc (AIM:IVO) licenses Meningitis B vaccinehttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3972757&HITNO=4&MSIZE=15&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Imperial%20College%20Innovations%20Limited&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3972757&THISHREF=http://c.moreover.com/click/here.pl%3fz2502588622%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3972757&HITNO=4&MSIZE=15&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Imperial%20College%20Innovations%20Limited&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3972757&THISHREF=http://c.moreover.com/click/here.pl%3fz2502588622%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comTherapeutics Daily: Imperial Innovations Group licenses Meningitis B vaccinehttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3976225&HITNO=5&MSIZE=15&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Imperial%20College%20Innovations%20Limited&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3976225&THISHREF=http://c.moreover.com/click/here.pl%3fz2504303070%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3976225&HITNO=5&MSIZE=15&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Imperial%20College%20Innovations%20Limited&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3976225&THISHREF=http://c.moreover.com/click/here.pl%3fz2504303070%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comBionity.com: Imperial Innovations Group signs license agreement with Novartis ...http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3978499&HITNO=6&MSIZE=15&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Imperial%20College%20Innovations%20Limited&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3978499&THISHREF=http://c.moreover.com/click/here.pl%3fz2505310131%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3978499&HITNO=6&MSIZE=15&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Imperial%20College%20Innovations%20Limited&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3978499&THISHREF=http://c.moreover.com/click/here.pl%3fz2505310131%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comZibb: Imperial Innovations Group signs license agreement with Novartis Vaccines and Diagnosticshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3978297&HITNO=7&MSIZE=15&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Imperial%20College%20Innovations%20Limited&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3978297&THISHREF=http://c.moreover.com/click/here.pl%3fz2505214763%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3978297&HITNO=7&MSIZE=15&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Imperial%20College%20Innovations%20Limited&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3978297&THISHREF=http://c.moreover.com/click/here.pl%3fz2505214763%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comIndividual.com: Imperial Innovations in meningitis vaccine licensing deal with Novartishttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3978736&HITNO=8&MSIZE=15&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Imperial%20College%20Innovations%20Limited&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3978736&THISHREF=http://c.moreover.com/click/here.pl%3fz2505438810%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3978736&HITNO=8&MSIZE=15&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Imperial%20College%20Innovations%20Limited&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3978736&THISHREF=http://c.moreover.com/click/here.pl%3fz2505438810%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comScience Business: Imperial Innovations Group plc (AIM:IVO) licenses Meningitis B vaccinehttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3972534&HITNO=9&MSIZE=15&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Imperial%20College%20Innovations%20Limited&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3972534&THISHREF=http://c.moreover.com/click/here.pl%3fz2502454121%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3972534&HITNO=9&MSIZE=15&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Imperial%20College%20Innovations%20Limited&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3972534&THISHREF=http://c.moreover.com/click/here.pl%3fz2502454121%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharma Live: Imperial Innovations grants exclusive IP license to Novartis for Meningitis B vaccinehttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3969780&HITNO=10&MSIZE=15&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Imperial%20College%20Innovations%20Limited&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3969780&THISHREF=http://c.moreover.com/click/here.pl%3fz2501016831%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3969780&HITNO=10&MSIZE=15&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Imperial%20College%20Innovations%20Limited&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3969780&THISHREF=http://c.moreover.com/click/here.pl%3fz2501016831%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comProactive Investors.co.uk: Imperial Innovations Group plc (AIM:IVO) licenses Meningitis B vaccinehttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3971043&HITNO=11&MSIZE=15&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Imperial%20College%20Innovations%20Limited&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3971043&THISHREF=http://c.moreover.com/click/here.pl%3fz2501614260%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3971043&HITNO=11&MSIZE=15&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Imperial%20College%20Innovations%20Limited&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3971043&THISHREF=http://c.moreover.com/click/here.pl%3fz2501614260%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comBioPortfolio: Novartis Nabs Imperial Colleges Preclinical Meningitis B Vaccinehttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3969755&HITNO=12&MSIZE=15&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Imperial%20College%20Innovations%20Limited&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3969755&THISHREF=http://c.moreover.com/click/here.pl%3fz2501006001%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3969755&HITNO=12&MSIZE=15&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Imperial%20College%20Innovations%20Limited&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3969755&THISHREF=http://c.moreover.com/click/here.pl%3fz2501006001%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comGenetic Engineering News: Cell Medica strengthens team with key appointment to senior managementhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3861546&HITNO=13&MSIZE=15&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Imperial%20College%20Innovations%20Limited&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3861546&THISHREF=http://c.moreover.com/click/here.pl%3fz2444505398%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3861546&HITNO=13&MSIZE=15&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Imperial%20College%20Innovations%20Limited&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3861546&THISHREF=http://c.moreover.com/click/here.pl%3fz2444505398%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comBionity.com: Selective targeting of apoptotic cellshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3856969&HITNO=14&MSIZE=15&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Imperial%20College%20Innovations%20Limited&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3856969&THISHREF=http://c.moreover.com/click/here.pl%3fz2442682728%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3856969&HITNO=14&MSIZE=15&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Imperial%20College%20Innovations%20Limited&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3856969&THISHREF=http://c.moreover.com/click/here.pl%3fz2442682728%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharmCast: